{"transactions":[{"id":793767,"issuer":{"id":5561,"kind":"organization","name":"Prelude Therapeutics Inc"},"owners":[{"id":49951,"kind":"person","name":"Morris Charles Q","position":1,"cik":"0001489966","reported_name":"Morris Charles Q","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-05-04T20:10:00.000Z","date":"2026-05-01","kind":"grant","planned":false,"acquired":true,"shares":450000,"price":4.7,"value":2115000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 25% of the total shares on May 1, 2027, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":450000,"derivative":{"exercise_price":4.7,"expiration_date":"2036-04-30","underlying":"Common Stock","underlying_shares":450000},"source":{"system":"sec-edgar","filing":"0001489966-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1489966/000148996626000004/primarydocument.xml","form_type":"4"}},{"id":1263724,"issuer":{"id":73047,"kind":"organization","name":"LAVA Therapeutics NV","symbol":"LVTX"},"owners":[{"id":49951,"kind":"person","name":"Morris Charles Q","position":1,"cik":"0001489966","reported_name":"Morris Charles Q","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Share Options (Right to Buy)","published_at":"2025-02-19T01:15:09.000Z","date":"2025-02-13","kind":"grant","planned":false,"acquired":true,"shares":130850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option vest in 48 equal monthly installments beginning on March 13, 2025, provided the Reporting Person remains in a service relationship with the Issuer or a subsidiary of the Issuer on each such vesting date."}],"balance_after":130850,"derivative":{"exercise_price":0.93,"expiration_date":"2035-03-12","underlying":"Common Shares","underlying_shares":130850},"source":{"system":"sec-edgar","filing":"0001415889-25-004525","document":"form4-02182025_080205.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1489966/000141588925004525/form4-02182025_080205.xml","form_type":"4"}},{"id":3241192,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":49951,"kind":"person","name":"Morris Charles Q","position":1,"cik":"0001489966","reported_name":"Morris Charles Q","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-02-28T21:15:18.000Z","date":"2020-02-26","kind":"sale","acquired":false,"shares":1256,"price":17.933,"value":22523.848,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the issuer's award agreement under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":33744,"source":{"system":"sec-edgar","filing":"0001209191-20-013793","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1489966/000120919120013793/doc4.xml","form_type":"4"}},{"id":3252918,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":49951,"kind":"person","name":"Morris Charles Q","position":1,"cik":"0001489966","reported_name":"Morris Charles Q","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-24T23:00:25.000Z","date":"2020-02-20","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the stock option shall vest on February 20, 2021, and the remaining shares shall vest in substantially equal monthly\ninstallments over the following three years, subject to continued service with RDUS through such dates."}],"balance_after":30000,"derivative":{"exercise_price":19.96,"expiration_date":"2030-02-20","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-20-012155","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1489966/000120919120012155/doc4.xml","form_type":"4"}},{"id":3252917,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":49951,"kind":"person","name":"Morris Charles Q","position":1,"cik":"0001489966","reported_name":"Morris Charles Q","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-02-24T23:00:25.000Z","date":"2020-02-20","kind":"grant","acquired":true,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were acquired pursuant to a restricted stock unit award under the 2018 Stock Option and Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of RDUS common stock. The restricted stock units vest in three substantially equal annual installments on each of the first three anniversaries of the grant date of February 20, 2020, subject to continued service with RDUS through such dates."}],"balance_after":35000,"source":{"system":"sec-edgar","filing":"0001209191-20-012155","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1489966/000120919120012155/doc4.xml","form_type":"4"}},{"id":3632127,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":49951,"kind":"person","name":"Morris Charles Q","position":1,"cik":"0001489966","reported_name":"Morris Charles Q","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-26T23:16:30.000Z","date":"2019-02-22","kind":"grant","acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the stock option shall vest on February 22, 2020, and the remaining shares shall vest in substantially equal monthly\ninstallments over the following three years, subject to continued service with RDUS through such dates."}],"balance_after":55000,"derivative":{"exercise_price":19.18,"expiration_date":"2029-02-22","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001209191-19-013718","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1489966/000120919119013718/doc4.xml","form_type":"4"}},{"id":3632126,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":49951,"kind":"person","name":"Morris Charles Q","position":1,"cik":"0001489966","reported_name":"Morris Charles Q","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-02-26T23:16:30.000Z","date":"2019-02-22","kind":"grant","acquired":true,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were acquired pursuant to a restricted stock unit award under the 2018 Stock Option and Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of RDUS common stock. The restricted stock units vest in four substantially equal annual installments on each of the first four anniversaries of the grant date of February 22, 2019, subject to continued service with RDUS through such dates."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001209191-19-013718","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1489966/000120919119013718/doc4.xml","form_type":"4"}},{"id":3825436,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":49951,"kind":"person","name":"Morris Charles Q","position":1,"cik":"0001489966","reported_name":"Morris Charles Q","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-09-05T21:32:35.000Z","date":"2018-09-04","kind":"grant","acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the stock option shall vest on September 4, 2019, and the remaining shares shall vest in substantially equal monthly installments over the following three years."}],"balance_after":130000,"derivative":{"exercise_price":19.93,"expiration_date":"2028-09-04","underlying":"Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0001209191-18-049624","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1489966/000120919118049624/doc4.xml","form_type":"4"}}]}